Immunomodulatory properties of exogenous surfactant in adult rat alveolar macrophages

Immunopharmacology and Immunotoxicology

Volumn 32, Issue 1, 2010, Pages 153-159

  Mittal, Neha ^a   Sanyal, Sankar Nath ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Alveolar macrophages; Apoptosis; Cytokines; Nitric oxide; Porcine surfactant; Reactive oxygen species

Indexed keywords

FLUORESCENT DYE; INTERLEUKIN 1BETA; LUNG SURFACTANT; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SURFACTANT;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; BLOOD LEVEL; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE RELEASE; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOMODULATION; LUNG ALVEOLUS MACROPHAGE; LUNG HOMOGENATE; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; RESPIRATORY BURST; RESPIRATORY DISTRESS SYNDROME; SPRAGUE DAWLEY RAT; SWINE;

ANIMALS; APOPTOSIS; CYTOKINES; IMMUNOLOGIC FACTORS; LUNG; MACROPHAGES, ALVEOLAR; MALE; NITRIC OXIDE; PULMONARY SURFACTANTS; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; RESPIRATORY BURST; SWINE;

ANIMALIA; ORYCTOLAGUS CUNICULUS; RATTUS; SUS;

EID: 77249146450     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923970903225119     Document Type: Article

References (35)

1. Wright JR.Pulmonary surfactant: a front line of lung host defense. J Clin Invest 2003;111:1453-1455.
2. Goerke J.Pulmonary surfactant: functions and molecular composition. Biochim Biophys Acta. 1998;1408:79-89.
3. Wright JR. Immunomodulatory functions of surfactant. Physiol Rev 1997;77:931-962.
4. Whitsett JA, Nogee LM, Weaver TE, Horowitz AD. Human surfactant protein B: structure, function, regulation and genetic disease. Physiol Rev 1995;75:749-757.
5. Wu H. Surfactant proteins A and D inhibit the growth of Gramnegative bacteria by increasing membrane permeability. J Clin Invest 2003;111:1589-1602.
6. Jobe A.H. Which surfactant for treatment of respiratory-distress syndrome? Lancet 2000;355:1380-1381.
7. Kremlev SG, Umstead TM, Phelps DS. Surfactant protein A regulates cytokine production in the monocytic cell line THP-1. Am J Physiol 1997;272:L996-1004.
8. Schwartz LW, Christman CA.Alveolar macrophage migration. Influence of lung lining material and acute lung insult. Am Rev Respir Dis 1979;128:429-439.
9. Suzuki Y, Nakai E-ichi, Ohkawa K-ichi.Experimental studies on the pulmonary surfactant. Reconstitution of surface active material. J Lipid Res 1982;23:53-61.
10. Raczka E, Kukowska-Latallo JF, Rymaszewski M, Chen C, Baker JR Jr. The effect of synthetic surfactant exposure on gene transfer in mouse lung in vivo. Gene Ther 1998;5:1333-1339.
11. Folkesson HG, Westrom BR, Karlsson BW. Effects of systemic and local immunization on alveolar epithelial permeability to protein in the rat. Am J Respir Crit Care Med 1998;157: 324-327.
12. Holt PG, Degebrodt A, Venaille T, O'Leary C, Krska K, Flexman J, Farrell H, Shellam, G, et al. Preparation of interstitial lung cells by enzymatic digestion of tissue slices: preliminary characterization by morphology and performance in functional assays. Immunology 1985;54:139-147.
13. Steinmiller C, Ullmann GF, Matthes MLL, Emmendorffer A. Local activation of nonspecific defense against a respiratory modal infection by application of interferon-?. Am J Respir Cell Mol Biol 2000;22:481-490.
14. Lemaire I, Lean M. Modulation of lung-associated NK-activity by resident and activated alveolar macrophages. Immunol Invest 1990;19:27-40.
15. Green SJ, Crawford RM, Hockmeyer JT, Meltzer MS, Naey CA. Leishmania major amastigotes initiate the L-arginine dependent killing mechanism in IFN-?-stimulated macrophages by induction of tumor necrosis factor-alpha. J Immunol 1990;145:4290-4297.
16. Kerecman J, Mustafa SB, Vasquez MM, Dixon PS, Catro R. Immunosuppressive properties of surfactant in alveolar macrophage NR8383. Inflamm Res 2008;57:118-125.
17. Subhashini J, Mahipal SVK, Reddy MC, Reddy MM, Rachamallu A, Reddanna P. Molecular mechanism in C-phycocyanin induced apoptosis in human chronic myeloid leukemia cell line-K562. Biochem Pharmacol 2004;68: 453-462.
18. Pearse AGE. In Histochemistry, Theoretical and Applied, 3rd ed., vol.1 . London: Churchill Livingstone, 1968; p. 660.
19. Thomassen MJ, Antal JM, Connors MJ, Meeker DP, Wiedemann HP. Characterization of exosurf (surfactant)-mediated suppression of stimulated human alveolar macrophages cytokine responses. Am J Resp Cell Mol Biol 1994;10:399-404.
20. Suresh GK, Soll RF. Overview of surfactant replacement trials. J Perinatol 2005;25 Suppl 2:S40-S44.
21. Willson DF, Thomas NJ, Markovitz BP, Bauman LA, Dicarlo JV, Pon S, et al. Effect of exogenous surfactant (calfactant) in pediatric acute lung injury. A randomized controlled trial. JAMA 2005;293:470-476.
22. Ahvazi BC, Jacobs P, Stevenson MM. Role of macrophage-derived nitric oxide in suppression of lymphocyte proliferation during blood-stage malaria. J Leuko Biol 1995;58:23-31.
23. Sharma A, Kabilan L. Regulation of nitric oxide production by cytokines in human macrophages: possible role in P. vivax malaria. Indian J Biochem Biophys 2000;37:313-317.
24. Allen JN, Moore SA, Pope-Harman AL, Marsh CB, Wewers MD. Immunosuppressive properties of surfactant and plasma on alveolar macrophages. J Lab Clin Med 1995;125:356-369.
25. Gong Q, Xu JF, Yin H, Liiu SF, Duan LH, Bian ZL. Protective effect of antagonist of high mobility group box 1 on lipopolysaccharide induced acute lung injury in mice. Scand J Immunol 2009;69:29-35.
26. Weid VT, Kopf M, Kohler G, Langhorne J. The immune response to Plasmodium chabaudi malaria in interleukin-4-deficient mice. Eur J Immunol 1994;24:2285-2293.
27. Gazzinelli RT, Eltoum I, Wynu TA, Sher A. Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-alpha and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation. J Immunol 1993;151:3672-3681.
28. Miles PR, Bowman L, Rao KM, Baatz JE, Huffman L. Pulmonary surfactant inhibits LPS-induced nitric oxide production by alveolar macrophages. Am J Physiol 1999;276:L186-L196.
29. Hayakawa H, Giridhar G, Myrvik Q.N, Kucera, L. Pulmonary surfactant phospholipids modulate priming of rabbit alveolar macrophages for oxidative responses. J Leukoc Biol 1992; 51:379-385.
30. Hayakawa H, Myrvik QN, St.Clair, RW. Pulmonary surfactant inhibits priming of rabbit alveolar macrophage. Evidence that surfactant suppresses the alveolar macrophage in infant rabbits. Am Rev Respir Dis 1989;140:1390-1397.
31. Chao W, Spragg RG, Smith RM. Inhibitory effect of porcine surfactant on the respiratory burst oxidase in human neutrophils: attenuation of p47phox and p67phox membrane translocation as the mechanism. J Clin Invest 1995;96:2654-2660.
32. Katsura H, Kawada H, Konno K. Rat surfactant apoprotein A (SP-A) exhibits antioxidant effects on alveolar macrophages. Am J Respir Cell Mol. Biol. 1993;9:520-525.
33. Suwabe A, Otake K, Yakuwa N, Suzuki H, Ito M, Tomoike H, et al. Artificial surfactant (surfactant TA) modulates adherence and superoxide production of neutrophils. Am J Respir Crit Care Med. 1998;158:1890-1899.
34. Srisook K, Cha YN. Biphasic induction of heme oygenase-1 expression in macrophages stimulated with lipopolysaccharide. Biochem Pharma 2004;68:1709-1720.
35. Vandivier RW, Ogden CA, Fadok VA, Hoffmann PR, Brown KK, Botto M, et al. Role of surfactant proteins A, D and C1q in the clearance of apoptotic cells in vivo & in vitro: calreticulin and CD91 as a common collectin receptor complex. J Immunol 2002;169:3978-3986.